![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Molecular Pharmacology, Vol 10, 183-193, Copyright © 1974 by the American Society for Pharmacology and Experimental Therapeutics
1 Department of Pharmacology and Experimental Therapeutics, The Johns Hopkins University
School of Medicine, Baltimore, Maryland 21205
A variety of enzymatic treatments have been examined with regard to their effect on stereospecific [3H]naloxone binding to rat brain homogenates. Opiate receptor binding is sensitive to very low concentrations of trypsin (EC 3.4.4.4) and chymotrypsin (EC 3.4.4.5). Trypsin appears to decrease the number of opiate receptor binding sites, while chymotrypsin primarily lowers their affinity for opiates. Receptor binding is drastically reduced by very low concentrations of phospholipase A (EC 3.1.1.4), is decreased by higher concentrations of phospholipase C (EC 3.1.4.3), and appears relatively insensitive to phospholipase D (EC 3.1.4.4) and neuraminidase (EC 3.2.1.18). Small amounts of RNase (EC 2.7.7.16) and DNase (EC 3.1.4.5) are without effect. Trypsin and chymotrypsin decrease receptor binding in a biphasic fashion, suggesting the presence of more than one population of sites sensitive to proteolysis. By contrast, the phospholipases degrade binding in a monophasic fashion. Thus the opiate receptor appears to be a membrane-bound complex whose stereospecific binding is dependent upon the integrity of both proteins and phospholipids.
Note:
ACKNOWLEDGMENTS
The authors gratefully thank Drs. Pedro
Cuatrecasas, Donald Coffey, Indu Parikh, and
Steven March for their helpful discussions and
suggestions, and Dr. Alan Goldberg for measuring
choline levels.
This article has been cited by other articles:
|
|
 |
|
  G. P. Brown and G. W. Pasternak 3H-Naloxone Benzoylhydrazone Binding in MOR-1-Transfected Chinese Hamster Ovary Cells: Evidence for G-Protein-Dependent Antagonist Binding J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 376 - 381. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. Chen, J.-C. Xue, J. Zhu, Y.-W. Chen, S. Kunapuli, J. K. d. Riel, L. Yu, and L.-Y. Liu-Chen Characterization of Irreversible Binding of [IMAGE]-Funaltrexamine to the Cloned Rat µ Opioid Receptor J. Biol. Chem., July 28, 1995; 270(30): 17866 - 17870. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Grevel and W Sadee An opiate binding site in the rat brain is highly selective for 4,5-epoxymorphinans Science, September 16, 1983; 221(4616): 1198 - 1201. [Abstract] [PDF]
|
|
|
|
|
|
G. Pasternak, Childers SR, and S. Snyder Opiate analgesia: evidence for mediation by a subpopulation of opiate receptors Science, May 2, 1980; 208(4443): 514 - 516. [Abstract] [PDF]
|
|
|
|
|
|
F. Craves, B Zalc, L Leybin, N Baumann, and H. Loh Antibodies to cerebroside sulfate inhibit the effects of morphine and beta-endorphin Science, January 4, 1980; 207(4426): 75 - 76. [Abstract] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
